Outcomes of Treatment With Etrasimod in Patients With Ulcerative Colitis and Their Association With Faecal Calprotectin and CRP Levels
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial
J Crohns Colitis 2024 Jun 03;18(6)885-894, AJ Yarur, MV Chiorean, J Panés, V Jairath, J Zhang, CJ Rabbat, WJ Sandborn, S Vermeire, L Peyrin-BirouletFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.